Computed Tomography Imaging Market Size, Share, Industry Analysis and Global Forecast to 2027 | Reports and Data

Increasing occurrences of chronic diseases is one of the significant factors influencing market growth.

The global computed tomography imaging market is expected to reach USD 9.13 Billion by 2027, according to a new report by Reports and Data. Rise in the geriatric population is one of the significant factors influencing market growth. It has been estimated that by 2050 approximately 16% of the global population will be aged more than 65 years, which is expected to increase fivefold since 1950. Forecasts from the World Health Organization (WHO), United Nations (UN), and the EU commission all indicate aging as a significant challenge for society, which demands concentrated efforts to meet the requirements of the elderly. Heart disease, cancer, and stroke have been the primary chronic conditions that have had the highest impact on the geriatric population, particularly in high-income countries. Thus, the increasing prevalence of diseases in the growing geriatric population is likely to propel the growth of the market in the forecast period.

Increasing awareness to diagnose disease at an early stage is likely to boost the market demand. Detection of diseases such as cancer at an early stage significantly increases the chances for survival. Creating awareness to encourage early diagnosis and screening are the crucial steps responsible for early detection diseases, including cardiovascular and musculoskeletal, among others. Identifying likely warning symptoms of diseases and taking rapid measures is necessary for early diagnosis. Greater awareness of probable symptoms of diseases amongst physicians, nurses, and other healthcare providers, in addition to the general public, would positively impact the recovery rate and hence would be instrumental in increasing the market demand.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2435

Market Overview:

The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.

The report has gather vital information about recent mergers and acquisitions, joint ventures, collaborations, partnerships, brand promotions, R&D activities, and government and corporate deals, among others through extensive primary and secondary research. The report also offers detailed analysis of each competitor along with their financial standing, global market position, product portfolio, manufacturing and production capacity, and business expansion plans.

The report offers a comprehensive overview of the regional bifurcation of the market with respect to market share, market size, revenue growth, import/export, production and consumption patterns, macro and micro economic growth factors, regulatory framework, investment and funding opportunities, and presence of key players in each region including North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. The report offers a country-wise analysis to further discuss the revenue growth and lucrative growth opportunities for the Computed Tomography Imaging market in these key regions.

Further key findings from the report suggest

• By technology, high-end slice technology contributed to the largest market share in 2018. High-end slice technology such as 256 or 320 slice systems provide superior image quality and results in better diagnoses.

• By application, oncology dominated the market in 2018 and is likely to grow at a rate of 5.4% in the forecast period. Cancer is the second foremost cause of death worldwide and accounts for an estimated 9.6 million deaths in 2018. Detection of cancer at an early stage significantly increases the chances for survival. Creating awareness to encourage early diagnosis and screening are the crucial steps responsible for early detection of cancer.

• By end-user, ambulatory imaging centers are expected to witness the fastest growth rate of 6.5% in the period 2019-2027.

• North America contributed to the largest market share in 2018 and is likely to have a CAGR of 5.3% in the period 2019-2027. The market dominance is owing to the higher acceptance of advanced technologies, well-established healthcare facilities, and the presence of leading market players in the region.

• Key participants include Canon Medical Systems, GE Healthcare, Koning Corporation, Fujifilm Holdings Corporation, Neusoft Medical Systems Corporation Limited, Siemens Healthineers, Hitachi Healthcare Systems, Neurologica Corporation, Shenzhen Anke High-Tech Co., and Koninklijke Philips NV, among others.

For the purpose of this report, Reports and Data have segmented the global computed tomography imaging market on the basis of technology, application, end-users, and region:

Technology Outlook (Revenue, USD Million; 2016-2027)

• Low-End Slice Technology
• Mid-End Slice Technology
• High-End Slice Technology

Application Outlook (Revenue, USD Million; 2016-2027)

• Oncology
• Cardiovascular
• Neurology
• Musculoskeletal
• Others

End-Users Outlook (Revenue, USD Million; 2016-2027)

• Hospitals
• Contract Research Organizations
• Ambulatory Imaging Centers

Regional Outlook (Revenue, USD Million; 2016-2027)

• North America
o U.S
• Europe
o U.K
o France
• Asia Pacific
o China
o India
o Japan
• Latin America
o Brazil
• MEA

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2435

Thank you for reading our report. For customization inquiry or further information, please connect with us and we will ensure you get the report that meets your requirements.

Read More Reports:-

Bioreactors and Fermenters Market @ https://www.google.bf/url?q=https://www.reportsanddata.com/report-detail/bioreactors-and-fermenters-market

Healthcare Workforce Management System Market @ https://www.google.gy/url?q=https://www.reportsanddata.com/report-detail/healthcare-workforce-management-system-market

Contact Us:

John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

This release was published on openPR.